Gut-derived systemic inflammation as a driver of cerebral dysfunction in metabolic dysfunction-associated steatotic liver disease (MASLD) (360G-Wellcome-228315_Z_23_Z)
People with metabolic dysfunction-associated steatotic liver disease (MASLD), commonly known as fatty liver disease, show signs of brain inflammation and are at higher risk of developing neurogenerative diseases. Often people with MASLD show signs of poor gut microbiome health, which has been linked to various neurodegenerative diseases. We believe that gut disruption during MASLD causes downstream inflammation within the brain, laying the seed for neurodegenerative disease in later life. By using a mouse model of MASLD, we will understand the changes in the gut and brain following an unhealthy diet and accumulation of fat in the liver by looking at genes, proteins, energy products, and different gut bacteria. With the mean age of MASLD diagnosis being 50 years old, we will undertake a long-term dietary intervention to minimise or reverse these changes, taking into consideration the additional impact of ageing on the body. We also hope to recapture some of the effects of MASLD in a 3D intestine model using human cell lines, by adding harmful microbiome products, modelling inflammation, and reducing the oxygen levels. Together, these experiments will help us to understand the gut and brain relationship in MASLD and why neurodegenerative diseases are more common in this disease.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.